Leukemia & lymphoma/Leukemia and lymphoma Journal Citation Rate 2026
1026-8022
eISSN 1029-2403
Taylor & Francis
CH
Q3 Quartile
About Leukemia & lymphoma/Leukemia and lymphoma
Leukemia & lymphoma/Leukemia and lymphoma (LLL) is a peer-reviewed academic journal, published by Taylor & Francis in CH, catalogued under ISSN 1026-8022 (e-ISSN 1029-2403). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 1.36 (Q3 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model.
Leukemia & lymphoma/Leukemia and lymphoma Citation Rate 2026 — In Context
Leukemia & lymphoma/Leukemia and lymphoma has a 2025 2-Year Citation Rate (OpenAlex) of 1.36, placing it in the Q3 quartile. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.
Leukemia & lymphoma/Leukemia and lymphoma operates a subscription-based publishing model — readers access articles through institutional subscriptions or pay-per-view.
Researchers looking to publish in Leukemia & lymphoma/Leukemia and lymphoma should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Leukemia & lymphoma/Leukemia and lymphoma against similar journals in the field, use our journal comparison tool.
| ISSN (Print) | 1026-8022 |
|---|---|
| ISSN (Online) | 1029-2403 |
| Publisher | Taylor & Francis |
| Country | Switzerland |
| APC / Cost | Inquire with Publisher |
In-depth profile & metrics
Leukemia & lymphoma/Leukemia and lymphoma is published by Taylor & Francis and based in Switzerland.
Leukemia & lymphoma/Leukemia and lymphoma is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.
Its most recent citation rate stands at 1.363.
Links
Continue on JournalsHub
Put what you just read into practice with these free tools.
Frequently Asked Questions about Leukemia & lymphoma/Leukemia and lymphoma
Live Indexing Status
Updated April 2026Track real-time indexing metrics to ensure this journal meets your academic requirements.
Citation Rate
Historical Trend
Initial data points onlyCitation Rate by Year
| Year | Value | Source |
|---|---|---|
| 2025 | 1.363 | 2-Year Mean Citedness (OpenAlex) |
Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.
Explore More Journals
Metadata
Last updated: Apr 24, 2026
Updated by: openalex_bulk
OpenAlex ID: S27064115
Get weekly updates
Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.